Literature DB >> 26710978

The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.

E Galaj1, J Haynes2, R Nisanov1, S Ananthan3, R Ranaldi4.   

Abstract

BACKGROUND: Pharmacotherapeutic agents that could facilitate extinction of cocaine cues would be useful in the treatment of cocaine addiction. We tested whether SR 21502, a selective dopamine (DA) D3 receptor antagonist, can facilitate extinction of cocaine conditioned place preference (CPP) in rats.
METHODS: In experiment 1, cocaine (10mg/kg) CPP was first established and then extinguished. During the extinction phase the rats were injected with SR 21502 and placed in the previously cocaine-paired compartment for four sessions and vehicle in the other compartment on four alternating sessions. The rats were then tested again for cocaine CPP. In experiment 2, different groups of rats were trained to associate SR 21502 with one compartment and saline with the other.
RESULTS: In experiment 1, the animals spent significantly more time in the cocaine-paired compartment after cocaine conditioning than they did before conditioning. Subsequently, the animals treated with SR 21502 during the extinction phase spent significantly less time in the cocaine-paired compartment than the vehicle group. In experiment 2, animals conditioned with SR 21502 preferred neither side of the CPP apparatus, indicating that SR 21502 produced no effects of its own.
CONCLUSIONS: These findings suggest that treatment with SR 21502, a DA D3 receptor antagonist, in the presence of cocaine cues can facilitate extinction of cocaine CPP and further suggest that this compound might be an effective cocaine addiction treatment.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Cocaine; Conditioned place preference; D3 receptor antagonist; Extinction; Reward

Mesh:

Substances:

Year:  2015        PMID: 26710978      PMCID: PMC4724481          DOI: 10.1016/j.drugalcdep.2015.11.030

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine.

Authors:  C L Duvauchelle; A Ikegami; E Castaneda
Journal:  Behav Neurosci       Date:  2000-12       Impact factor: 1.912

2.  The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.

Authors:  E Galaj; S Ananthan; M Saliba; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2013-09-15       Impact factor: 4.530

3.  Repeated testing attenuates conditioned place preference with cocaine.

Authors:  M T Bardo; J L Neisewander; J S Miller
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy.

Authors:  G A Barr; N S Sharpless; S Cooper; S R Schiff; W Paredes; W H Bridger
Journal:  Life Sci       Date:  1983-10-03       Impact factor: 5.037

5.  The selective dopamine D3 receptor antagonist SB-277011A significantly accelerates extinction to environmental cues associated with cocaine-induced place preference in male Sprague-Dawley rats.

Authors:  Charles R Ashby; Onarae V Rice; Christian A Heidbreder; Eliot L Gardner
Journal:  Synapse       Date:  2015-07-14       Impact factor: 2.562

6.  Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration.

Authors:  H O Pettit; H T Pan; L H Parsons; J B Justice
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

7.  Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.

Authors:  Luigi Cervo; Arianna Cocco; Cinzia Petrella; Christian A Heidbreder
Journal:  Int J Neuropsychopharmacol       Date:  2006-01-23       Impact factor: 5.176

8.  Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions.

Authors:  C Spyraki; H C Fibiger; A G Phillips
Journal:  Brain Res       Date:  1982-12-16       Impact factor: 3.252

Review 9.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

10.  Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice.

Authors:  Rui Song; Hai-Ying Zhang; Xiao-Qing Peng; Rui-Bin Su; Ri-Fang Yang; Jin Li; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2013-05-02       Impact factor: 5.250

View more
  5 in total

1.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

2.  KCNQ2/3 channel agonist flupirtine reduces cocaine place preference in rats.

Authors:  James Mooney; Scott M Rawls
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

3.  (-)-Stepholidine blocks expression, but not development, of cocaine conditioned place preference in rats.

Authors:  A Bennett; E Barrera; H Namballa; W Harding; R Ranaldi
Journal:  Neurosci Lett       Date:  2020-06-09       Impact factor: 3.046

Review 4.  A mechanistic overview of approaches for the treatment of psychostimulant dependence.

Authors:  Kathrine Louise Jensen; Søren Brøgger Jensen; Kenneth Lindegaard Madsen
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

Review 5.  Making Sense of: Sensitization in Schizophrenia.

Authors:  Ana Weidenauer; Martin Bauer; Ulrich Sauerzopf; Lucie Bartova; Nicole Praschak-Rieder; Harald H Sitte; Siegfried Kasper; Matthäus Willeit
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-31       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.